Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)
Clinical trial NCT05907603 · COMPLETED
Trial details
- NCT number
- NCT05907603
- Sponsor
- Kai Lin Xu，MD
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2024-08-31
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.